{
    "id": 16248,
    "fullName": "SFPQ - TFE3",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SFPQ-TFE3 (also referred to as PSF-TFE3) results from the fusion of SFPQ and TFE3 (PMID: 19809274). SFPQ-TFE3 results in the up-regulation of microphthalmia-associated transcription factor, tyrosinase (TYR), and tyrosinase-related protein 1 (TYRP1) (PMID:19809274).",
            "references": [
                {
                    "id": 4229,
                    "pubMedId": 19809274,
                    "title": "Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19809274"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6421,
        "geneSymbol": "SFPQ",
        "terms": [
            "SFPQ",
            "POMP100",
            "PPP1R140",
            "PSF"
        ]
    },
    "variant": "SFPQ - TFE3",
    "createDate": "01/06/2016",
    "updateDate": "01/06/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 7030,
                "geneSymbol": "TFE3",
                "terms": [
                    "TFE3",
                    "bHLHe33",
                    "RCCP2",
                    "RCCX1",
                    "TFEA"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 15803,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BEZ235 inhibited proliferation of a patient-derived renal cell carcinoma cell line harboring SFPQ-TFE3 in culture and inhibited tumor growth in xenograft models, with increased growth inhibition compared to PI3K or mTOR inhibition alone (PMID: 30061365).",
            "molecularProfile": {
                "id": 16521,
                "profileName": "SFPQ - TFE3"
            },
            "therapy": {
                "id": 672,
                "therapyName": "BEZ235",
                "synonyms": null
            },
            "indication": {
                "id": 4450,
                "name": "renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 13814,
                    "pubMedId": 30061365,
                    "title": "Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30061365"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 16521,
            "profileName": "SFPQ - TFE3",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}